Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

VZV antibody

VZV Reactivity: Varicella Zoster Virus (VZV) IF, IHC (fro) Host: Mouse Monoclonal 371 unconjugated
Catalog No. ABIN180987
  • Target See all VZV products
    VZV (Varicella Zoster Virus (VZV))
    Reactivity
    • 2
    • 1
    Varicella Zoster Virus (VZV)
    Host
    • 3
    Mouse
    Clonality
    • 3
    Monoclonal
    Conjugate
    • 2
    • 1
    This VZV antibody is un-conjugated
    Application
    • 2
    • 2
    • 1
    • 1
    Immunofluorescence (IF), Immunohistochemistry (Frozen Sections) (IHC (fro))
    Characteristics
    Synonyms: Varicella-zoster virus, Human herpesvirus 3, Varicella Zoster Virus nucleocapsid
    Purification
    Purified
    Clone
    371
    Isotype
    IgG1
  • Application Notes
    Immunofluorescence: 1/10-1/50. Immunohistochemistry on Frozen Sections: 1/10-1/50.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Restrictions
    For Research Use only
  • Concentration
    0.1 mg/mL
    Buffer
    PBS, pH 7.2 containing 0.09 % Sodium Azide as preservative.
    Preservative
    Sodium azide
    Precaution of Use
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C/-20 °C
    Storage Comment
    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer. Avoid repeated freezing and thawing.
    Shelf life: one year from despatch.
    Expiry Date
    12 months
  • Target
    VZV (Varicella Zoster Virus (VZV))
    Alternative Name
    VZV / HHV-3 (VZV Products)
    Target Type
    Virus
    Background
    The varicella-zoster virus is one of the eight herpesviruses known to affect humans (and other vertebrates). Primary VZV infection results in chickenpox (varicella), which may rarely result in complications including VZV encephalitis. Even when clinical symptoms of varicella have resolved, VZV remains dormant in the nervous system of the host in the trigeminal and dorsal root ganglia. In about 10-20 % of cases, VZV later reactivates later in life to produce herpes zoster (shingles) and its associated sequelae including post-herpetic neuralgia, zoster multiplex, myelitis, herpes ophthalmicus, or zoster sine herpete. Its lipid envelope encloses the nucleocapsid of 162 capsomeres arranged in a hexagonal form.Synonyms: HHV3, Varizella zoster
You are here:
Support